Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion description "[The use of enoxacin in human cell cultures and xenografted, orthotopic, and metastatic mouse models reveals a TRBP-dependent and cancer-specific growth-inhibitory effect of the drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion evidence source_evidence_literature NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion SIO_000772 21368194 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion wasDerivedFrom befree-20140225 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion wasGeneratedBy ECO_0000203 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.